KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Return on Sales (2016 - 2025)

Fulgent Genetics' Return on Sales history spans 11 years, with the latest figure at 0.39% for Q4 2025.

  • For Q4 2025, Return on Sales fell 14.0% year-over-year to 0.39%; the TTM value through Dec 2025 reached 0.02%, down 3.0%, while the annual FY2025 figure was 0.03%, 4.0% down from the prior year.
  • Return on Sales for Q4 2025 was 0.39% at Fulgent Genetics, up from 0.08% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.56% in Q1 2021 and bottomed at 3.15% in Q4 2022.
  • The 5-year median for Return on Sales is 0.1% (2024), against an average of 0.16%.
  • The largest annual shift saw Return on Sales tumbled -357bps in 2022 before it surged 244bps in 2024.
  • A 5-year view of Return on Sales shows it stood at 0.41% in 2021, then plummeted by -865bps to 3.15% in 2022, then skyrocketed by 40bps to 1.91% in 2023, then soared by 128bps to 0.53% in 2024, then fell by -27bps to 0.39% in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Return on Sales are 0.39% (Q4 2025), 0.08% (Q3 2025), and 0.24% (Q2 2025).